PDS Biotech (PDSB) Overview: Cancer Immunotherapies

<p>PDS Biotech (PDSB) is a clinical-stage immunotherapy company that has a growing pipeline of cancer immunotherapies and infectious disease vaccines. Frank Bedu-Addo, President and CEO of PDS Biotech, gives an overview of PDS Biotech, highlighting its new cancer drug, Versamune, which effectively delivers disease-specific antigens for in vivo uptake and processing. Tune in to find out more.</p><p><br></p>